SI
Sofinnova Investments Portfolio holdings
AUM
$1.63B
1-Year Est. Return
33.42%
1 Year Est. Return
+33.42%
AUM
$1.63B
AUM Growth
+$160M
(+11%)
Holding
67
Top Buys
| 1 | +$46.2M | |
| 2 | +$40.7M | |
| 3 | +$36.4M | |
| 4 |
United Therapeutics
UTHR
|
+$30.2M |
| 5 |
Glaukos
GKOS
|
+$25.5M |
Top Sells
| 1 | +$83M | |
| 2 | +$75.6M | |
| 3 | +$34.2M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$33.3M |
| 5 |
Insmed
INSM
|
+$30.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$32.5B
| $250M | 13.65% |
1,550,280
|
|
||
2
Gilead Sciences
GILD
$151B
| $139M | 7.6% |
1,252,312
+202,004
|
|
||
3
Vera Therapeutics
VERA
$2.83B
| $81.2M | 4.44% |
2,793,987
|
|
||
|
4
United Therapeutics
UTHR
$20.9B
| $79.9M | 4.37% |
190,626
+72,113
|
|
||
5
Jazz Pharmaceuticals
JAZZ
$10B
| $77.6M | 4.24% |
588,828
-105,268
|
|
||
6
AstraZeneca
AZN
$284B
| $63.2M | 3.46% |
823,933
+530,272
|
|
||
|
RAPP
7
Rapport Therapeutics
RAPP
$1.37B
| $57.8M | 3.16% |
1,947,579
-48,015
|
|
||
8
Boston Scientific
BSX
$137B
| $55.6M | 3.04% |
569,427
+138,227
|
|
||
9
DexCom
DXCM
$26.3B
| $52.5M | 2.87% |
779,616
+255,922
|
|
||
10
Intuitive Surgical
ISRG
$197B
| $49.6M | 2.71% |
110,896
+40,254
|
|
||
11
Axsome Therapeutics
AXSM
$7.52B
| $47.8M | 2.61% |
393,499
+299,889
|
|
||
12
Roivant Sciences
ROIV
$14.1B
| $47.6M | 2.61% |
3,149,270
+60,456
|
|
||
13
Vertex Pharmaceuticals
VRTX
$113B
| $46.2M | 2.52% |
+117,875
|
|
||
14
BridgeBio Pharma
BBIO
$14B
| $43.2M | 2.36% |
831,847
-161,246
|
|
||
15
Avidity Biosciences
RNA
$10.8B
| $38.2M | 2.09% |
875,925
+291,124
|
|
||
16
AbbVie
ABBV
$398B
| $35M | 1.91% |
150,966
-114,884
|
|
||
17
ArriVent BioPharma
AVBP
$1.01B
| $31.3M | 1.71% |
1,696,752
|
|
||
18
Cogent Biosciences
COGT
$6.01B
| $30.6M | 1.67% |
2,127,941
-227,564
|
|
||
|
19
Glaukos
GKOS
$6.24B
| $25.5M | 1.4% |
+312,994
|
|
||
|
20
IDEAYA Biosciences
IDYA
$2.95B
| $25.1M | 1.37% |
922,695
-1,225,100
|
|
||
21
Rhythm Pharmaceuticals
RYTM
$6.99B
| $24.9M | 1.36% |
246,966
-339,044
|
|
||
22
Akero Therapeutics
AKRO
| $22.5M | 1.23% |
473,625
-75,163
|
|
||
23
Apogee Therapeutics
APGE
$5.2B
| $22.5M | 1.23% |
565,417
+489,237
|
|
||
24
Exact Sciences
EXAS
$19.2B
| $20M | 1.09% |
365,000
+156,700
|
|
||
25
Immatics
IMTX
$1.35B
| $19M | 1.04% |
2,227,837
-12,691
|
|